Since Tg is produced only by well-differentiated thyroid cells, it is considered a reliable tumor marker for patients with DTC in the follow-up after total thyroidectomy and radioiodine ablation to monitor residual or recurrent disease [2]. The gene discussed is TG; the disease is neoplasm.